Nancy A. Grygiel - 03 Mar 2026 Form 4 Insider Report for AMGEN INC (AMGN)

Role: SVP & CCO
Signature: /s/ Nancy A. Grygiel
Issuer symbol: AMGN
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 20:38:47 UTC
Previous filing: 21 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Grygiel Nancy A.	SVP & CCO	ONE AMGEN CENTER DRIVE, THOUSAND OAKS	/s/ Nancy A. Grygiel	04 Mar 2026	0001816414

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Award		+2,010	+28%	$0.000000^*	9,249	03 Mar 2026	Direct	F1
holding	AMGN	Common Stock						105	03 Mar 2026	401(k) Plan	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include 110 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F2	These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.

Content

These shares include 110 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.